Clinical trial
Clonidine Versus Adenosine to Treat Neuropathic Pain
NCT00349921 · Wake Forest University Health Sciences, Other · Completed
Key facts
| NCT number | NCT00349921 |
|---|---|
| Title | Clonidine Versus Adenosine to Treat Neuropathic Pain |
| Official title | Clonidine Versus Adenosine to Treat Neuropathic Pain |
| Lead sponsor | Wake Forest University Health Sciences, Other |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pain |
| Intervention type | Drug |
| Interventions | clonidine, adenosine, placebo |
| Enrollment | 24 |
| Start date | Aug 1, 2004 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Jul 10, 2006 |
| Last update posted | Sep 10, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: